Cargando…
Genetic variants of PDGF signaling pathway genes predict cutaneous melanoma survival
To investigate whether genetic variants of platelet-derived growth factor (PDGF) signaling pathway genes are associated with survival of cutaneous melanoma (CM) patients, we assessed associations of single-nucleotide polymorphisms in PDGF pathway with melanoma-specific survival in 858 CM patients of...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650365/ https://www.ncbi.nlm.nih.gov/pubmed/29088810 http://dx.doi.org/10.18632/oncotarget.20245 |
_version_ | 1783272694496624640 |
---|---|
author | Li, Hong Wang, Yanru Liu, Hongliang Shi, Qiong Li, Hongyu Wu, Wenting Zhu, Dakai Amos, Christopher I. Fang, Shenying Lee, Jeffrey E. Li, Yi Han, Jiali Wei, Qingyi |
author_facet | Li, Hong Wang, Yanru Liu, Hongliang Shi, Qiong Li, Hongyu Wu, Wenting Zhu, Dakai Amos, Christopher I. Fang, Shenying Lee, Jeffrey E. Li, Yi Han, Jiali Wei, Qingyi |
author_sort | Li, Hong |
collection | PubMed |
description | To investigate whether genetic variants of platelet-derived growth factor (PDGF) signaling pathway genes are associated with survival of cutaneous melanoma (CM) patients, we assessed associations of single-nucleotide polymorphisms in PDGF pathway with melanoma-specific survival in 858 CM patients of M.D. Anderson Cancer Center (MDACC). Additional data of 409 cases from Harvard University were also included for further analysis. We identified 13 SNPs in four genes (COL6A3, NCK2, COL5A1 and PRKCD) with a nominal P < 0.05 and false discovery rate (FDR) < 0.2 in MDACC dataset. Based on linkage disequilibrium, functional prediction and minor allele frequency, a representative SNP in each gene was selected. In the meta-analysis using MDACC and Harvard datasets, there were two SNPs associated with poor survival of CM patients: rs6707820 C>T in NCK2 (HR = 1.87, 95% CI = 1.35-2.59, P(meta) = 1.53E-5); and rs2306574 T>C in PRKCD (HR = 1.73, 95% CI = 1.33-2.24, P(meta) = 4.56E-6). Moreover, CM patients in MDACC with combined risk genotypes of these two loci had markedly poorer survival (HR = 2.47, 95% CI = 1.58-3.84, P < 0.001). Genetic variants of rs6707820 C>T in NCK2 and rs2306574 T>C in PRKCD of the PDGF signaling pathway may be biomarkers for melanoma survival. |
format | Online Article Text |
id | pubmed-5650365 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-56503652017-10-30 Genetic variants of PDGF signaling pathway genes predict cutaneous melanoma survival Li, Hong Wang, Yanru Liu, Hongliang Shi, Qiong Li, Hongyu Wu, Wenting Zhu, Dakai Amos, Christopher I. Fang, Shenying Lee, Jeffrey E. Li, Yi Han, Jiali Wei, Qingyi Oncotarget Research Paper To investigate whether genetic variants of platelet-derived growth factor (PDGF) signaling pathway genes are associated with survival of cutaneous melanoma (CM) patients, we assessed associations of single-nucleotide polymorphisms in PDGF pathway with melanoma-specific survival in 858 CM patients of M.D. Anderson Cancer Center (MDACC). Additional data of 409 cases from Harvard University were also included for further analysis. We identified 13 SNPs in four genes (COL6A3, NCK2, COL5A1 and PRKCD) with a nominal P < 0.05 and false discovery rate (FDR) < 0.2 in MDACC dataset. Based on linkage disequilibrium, functional prediction and minor allele frequency, a representative SNP in each gene was selected. In the meta-analysis using MDACC and Harvard datasets, there were two SNPs associated with poor survival of CM patients: rs6707820 C>T in NCK2 (HR = 1.87, 95% CI = 1.35-2.59, P(meta) = 1.53E-5); and rs2306574 T>C in PRKCD (HR = 1.73, 95% CI = 1.33-2.24, P(meta) = 4.56E-6). Moreover, CM patients in MDACC with combined risk genotypes of these two loci had markedly poorer survival (HR = 2.47, 95% CI = 1.58-3.84, P < 0.001). Genetic variants of rs6707820 C>T in NCK2 and rs2306574 T>C in PRKCD of the PDGF signaling pathway may be biomarkers for melanoma survival. Impact Journals LLC 2017-08-14 /pmc/articles/PMC5650365/ /pubmed/29088810 http://dx.doi.org/10.18632/oncotarget.20245 Text en Copyright: © 2017 Li et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Li, Hong Wang, Yanru Liu, Hongliang Shi, Qiong Li, Hongyu Wu, Wenting Zhu, Dakai Amos, Christopher I. Fang, Shenying Lee, Jeffrey E. Li, Yi Han, Jiali Wei, Qingyi Genetic variants of PDGF signaling pathway genes predict cutaneous melanoma survival |
title | Genetic variants of PDGF signaling pathway genes predict cutaneous melanoma survival |
title_full | Genetic variants of PDGF signaling pathway genes predict cutaneous melanoma survival |
title_fullStr | Genetic variants of PDGF signaling pathway genes predict cutaneous melanoma survival |
title_full_unstemmed | Genetic variants of PDGF signaling pathway genes predict cutaneous melanoma survival |
title_short | Genetic variants of PDGF signaling pathway genes predict cutaneous melanoma survival |
title_sort | genetic variants of pdgf signaling pathway genes predict cutaneous melanoma survival |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650365/ https://www.ncbi.nlm.nih.gov/pubmed/29088810 http://dx.doi.org/10.18632/oncotarget.20245 |
work_keys_str_mv | AT lihong geneticvariantsofpdgfsignalingpathwaygenespredictcutaneousmelanomasurvival AT wangyanru geneticvariantsofpdgfsignalingpathwaygenespredictcutaneousmelanomasurvival AT liuhongliang geneticvariantsofpdgfsignalingpathwaygenespredictcutaneousmelanomasurvival AT shiqiong geneticvariantsofpdgfsignalingpathwaygenespredictcutaneousmelanomasurvival AT lihongyu geneticvariantsofpdgfsignalingpathwaygenespredictcutaneousmelanomasurvival AT wuwenting geneticvariantsofpdgfsignalingpathwaygenespredictcutaneousmelanomasurvival AT zhudakai geneticvariantsofpdgfsignalingpathwaygenespredictcutaneousmelanomasurvival AT amoschristopheri geneticvariantsofpdgfsignalingpathwaygenespredictcutaneousmelanomasurvival AT fangshenying geneticvariantsofpdgfsignalingpathwaygenespredictcutaneousmelanomasurvival AT leejeffreye geneticvariantsofpdgfsignalingpathwaygenespredictcutaneousmelanomasurvival AT liyi geneticvariantsofpdgfsignalingpathwaygenespredictcutaneousmelanomasurvival AT hanjiali geneticvariantsofpdgfsignalingpathwaygenespredictcutaneousmelanomasurvival AT weiqingyi geneticvariantsofpdgfsignalingpathwaygenespredictcutaneousmelanomasurvival |